RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 Advantage of Prasugrel over Clopidogrel Holds across Range of Patient- and Procedure-Related Factors
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 2
SP 9
OP 9
DO 10.1177/155989770800800205
UL http://mdc.sagepub.com/content/8/2/9.1.abstract
AB The advantage of prasugrel over clopidogrel in preventing stent thrombosis has been found to be maintained regardless of the time since the stenting procedure, the type of stent, or the ARC definition of thrombosis. The TRITON-TIMI 38 stent analysis showed that the drug led to a highly significant reduction in stent thrombosis over a broad array of clinical and procedural characteristics.